This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwarz, R. E. Articles by Hiserodt, J. C. Search for Related Content PubMed PubMed Citation Articles by Schwarz, R. E. Articles by Hiserodt, J. C.

Enhanced Antimetastatic Activity of Lymphokine-activated Killer Cells Purified and Expanded by Their Adherence to Plastic¹

Department of Pathology and Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15213

We have recently reported a simple and reproducible technique for the purification and rapid expansion of homogeneous populations of large granular lymphocytes expressing a natural killer cell phenotype and high levels of broad antitumor cytotoxic activity [lymphokine-activated killer (LAK) activity]. This technique exploits the observation that, in the presence of recombinant interleukin 2 (rIL-2), large granular lymphocytes/natural killer cells become adherent to plastic surfaces, actively proliferate, and acquire high levels of LAK activity. Because of their adherent properties these cells have been termed adherent LAK or A-LAK cells. The present studies investigate the antimetastatic effects of A-LAK cells in a syngeneic rat model of experimental pulmonary and hepatic metastases. For pulmonary metastases, F344 rats received i.v. injections with a natural killer-resistant mammary adenocarcinoma, MADB106, and, for hepatic metastases, animals received an intrasplenic injection of MADB106 tumor cells followed by surgical splenectomy. Three days later, the animals were treated with A-LAK cells alone, A-LAK cells plus rIL-2, or rIL-2 alone. These treatments were compared to immunotherapy using standard cultures of LAK cells (unfractionated spleen cells) and rIL-2. The results indicate that the administration of unfractionated LAK cells plus interleukin 2 (IL-2) was effective in reducing established lung or liver metastases in this rat model. However, the results also indicate that purified populations of A-LAK cells in combination with rIL-2 demonstrate dramatic and superior antimetastatic effects when compared to LAK cells cultured under standard conditions. The antimetastatic effects of standard LAK cells or A-LAK cells plus IL-2 translated into significant survival benefits compared to animals receiving no therapy or IL-2 therapy alone. Survival after therapy with A-LAK cells plus IL-2 was significantly prolonged compared to treatment with standard LAK cells. These data suggest that purified populations of LAK cells (derived from natural killer cells) may prove superior for adoptive immunotherapy in the clinical setting.

¹ This work was supported in part by Grants CA43765 and HL37638 from the NIH (J. C. H.) and by Grant Schw-368/1 from the Deutsche Forschungsgemeinschaft (R. E. S.).

² On sabbatical leave from the Institute of Oncology and Radiology, Pasterova 14, 11000 Belgrade, Yugoslavia.

³ To whom requests for reprints should be addressed, at Pittsburgh Cancer Institute, 3343 Forbes Avenue, Pittsburgh, PA 15213.

Received 6/ 6/88. Revised 10/ 7/88. Accepted 12/19/88.

This article has been cited by other articles:

				S. Li, J. Xu, V. P. Makarenkova, T. Tjandrawan, J. Vakkila, T. Reichert, W. Gooding, C. F. Lagenaur, C. L. Achim, W. H. Chambers, et al. A novel epitope of N-CAM defines precursors of human adherent NK cells J. Leukoc. Biol., December 1, 2004; 76(6): 1187 - 1199. [Abstract] [Full Text] [PDF]

				R. Gastpar, C. Gross, L. Rossbacher, J. Ellwart, J. Riegger, and G. Multhoff The Cell Surface-Localized Heat Shock Protein 70 Epitope TKD Induces Migration and Cytolytic Activity Selectively in Human NK Cells J. Immunol., January 15, 2004; 172(2): 972 - 980. [Abstract] [Full Text] [PDF]

				R. Glas, L. Franksson, C. Une, M.-L. Eloranta, C. Ohlen, A. Orn, and K. Karre Recruitment and Activation of Natural Killer (NK) Cells In Vivo Determined by the Target Cell Phenotype: An Adaptive Component of NK Cell-mediated Responses J. Exp. Med., January 3, 2000; 191(1): 129 - 138. [Abstract] [Full Text] [PDF]

				N. Quan, Z.-b. Zhang, M. K. Demetrikopoulos, R. P. Kitson, W. H. Chambers, R. H. Goldfarb, and J. M. Weiss Evidence for Involvement of B Lymphocytes in the Surveillance of Lung Metastasis in the Rat Cancer Res., March 1, 1999; 59(5): 1080 - 1089. [Abstract] [Full Text] [PDF]